ResMed (RMD) capital expenditure was $159M in FY2026 (+76% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2026
$159M
+76%
2025
$90M
-10%
2024
$99M
-26%
2023
$134M
-14%
2022
$156M
+34%
2021
$117M
+10%
2020
$106M
+37%
2019
$77M
+8%
2018
$71M
-0%
2017
$71M
+5%
2016
$68M
-6%
2015
$72M
-11%
2014
$81M
+13%
2013
$72M
+33%
2012
$54M
-26%
2011
$73M
+18%
2010
$62M
-46%
2009
$114M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q2 2026
$52M
Q1 2026
$34M
Q4 2025
$30M
Q3 2025
$46M
Q2 2025
$31M
Q1 2025
$21M
Q4 2024
$22M
Q3 2024
$20M
Q2 2024
$39M
Q1 2024
$23M
Q4 2023
$25M
Q3 2023
$41M
Source: RMD on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.